Action Point Financial Planning’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-14
Closed -$3.2K – 566
2026
Q2
$3.2K Buy
+14
New +$3.27K ﹤0.01% 2023

Other funds holding ASND

Action Point Financial Planning's ASND Position: Q3 2026 in Review

Action Point Financial Planning sold out of Ascendis Pharma (ASND) in Q3 2026, closing a stake of 14 shares — an estimated $3.2K sold.

Action Point Financial Planning first reported a position in ASND in Q2 2026 and held it in 1 quarter. The position peaked at $3.2K in Q2 2026. 347 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

  • Action Point Financial Planning reported no remaining Ascendis Pharma position as of Q3 2026 after selling out during the quarter.
  • Action Point Financial Planning sold 14 Ascendis Pharma shares in Q3 2026, an estimated $3.2K.
  • Action Point Financial Planning first reported a position in Ascendis Pharma in Q2 2026 and held it in 1 quarter.
  • Action Point Financial Planning's Ascendis Pharma position peaked at $3.2K in Q2 2026.
  • 347 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.

Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.